Scrip Regulatory Affairs
EU Drug and Medtech Regulation: a Deliberate Shift in Power Away from Member States
August 2013
In the field of pharmaceutical and medical device regulation in the EU, power is increasingly moving from member states to Brussels. This is largely a good thing for the life sciences industry as it will make Europe more competitive internationally.
This article was published in the August 2013 issue of Scrip Regulatory Affairs.
得意分野
Suggested News & Insights
Life Sciences College 2027Thursday, February 4, 2027Exclusive Fireside Chat: A Conversation With FDA's Chief CounselTuesday, January 12, 20277th Global IR Pitching @JPM 2027Tuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026Sidley Deals Honored at the IFLR Asia-Pacific Awards 2026November 17, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory